article · European Scientific Journal ESJ
Background: Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits without structural abnormalities. Though non-lethal, it significantly affects the quality of life of sufferers. In Sub-Saharan Africa, data on IBS are limited. Objective: Describe the clinical presentation of IBS and the quality of life among medical students in our country. Methods: A descriptive cross-sectional prospective study was conducted in two medical schools. Stratified sampling was employed to recruit a total of 260 students. Data gathered included sociodemographic details, Rome IV diagnostic criteria, Bristol stool scale scores, gastrointestinal symptoms, and quality-of-life predictors. Statistical analysis was done using IBM SPSS version 26. Results: Out of the 260 students, the prevalence of presumed IBS was 11.2%. IBS-C was most common (41.4%), followed by IBS-D (31%), IBS-M (20.7%), and unclassified (6.9%). IBS-C was significantly associated with females (p = 0.021, Cramer's V = 0.412), irregular meals (p = 0.013, Cramer's V = 0.519), and morning predominance of pain (p = 0.011, Cramer's V = 0.508). The triad: defecation-related abdominal pain, altered stool consistency, and altered stool frequency was present in 68.9% of students with IBS. Most students with IBS reported diffuse (62.1%), persistent (34.5%) abdominal pain with mixed triggers and relieving factors. Quality of life was altered in 58.6% of students with IBS, with 10.3% experiencing severe impairment. Conclusion: Presumed IBS among medical students in our study was non-negligible, with a predominance of IBS-C. Clinical profile was dominated by diffuse, persistent abdominal pain with multiple triggers. Quality of life was altered in most students with IBS.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.19044/esj.2026.v22n9p81
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.